Announced by CTBC Holding on behalf of Taiwan Life that the Taiwan Life Board passed the resolution for cumulative subordinated corporate bonds issuance.

1.Date of the board of directors resolution:2026/06/30
2.Name [issue no.__ of (secured, unsecured) corporate bonds of
___________ (company)]:The cumulative subordinated corporate bonds of Taiwan
Life Insurance Co., Ltd. in 2026.
3.Whether to adopt shelf registration (Yes/No):No.
4.Total amount issued:Up to NT$20 billion (or its equivalent in a foreign
currency), which will be issued domestically and/or offshore via the wholly-
owned foreign SPV (Taiwan Life Singapore Pte. Ltd.), in one or several
stages according to market conditions.
5.Face value per bond:Tentatively set at NT$ 1 million (It depends on market
conditions if the issuance is denominated in foreign currency).
6.Issue price:100% issue at the par value.
7.Issuance period:10 years or more.
8.Coupon rate:The Chairman or designated person is authorized to decide
depending on market conditions.
9.Types, names, monetary values and stipulations of collaterals:None.
10.Use of the funds raised by the offering and utilization plan:To enhance
working capital, strengthen financial structure, and increase capital
adequacy ratio.
11.Underwriting method:The Chairman or designated person is authorized to
decide.
12.Trustees of the corporate bonds:The Chairman or designated person is
authorized to decide.
13.Underwriter or agent:The Chairman or designated person is authorized
to decide.
14.Guarantor(s) for the issuance:The company will be the guarantor for
the international bond issued via the wholly-owned foreign SPV.
15.Agent for payment of the principal and interest:The Chairman or designated
person is authorized to decide.
16.Certifying institution:None.
17.Where convertible into shares, the rules for conversion:None.
18.Sell-back conditions:None.
19.Buyback conditions:The Chairman or designated person is authorized to
decide.
20.Reference date for any additional share exchange, stock swap, or
subscription:None.
21.Possible dilution of equity in case of any additional share exchange,
stock swap, or subscription:None.
22.Reasonableness and necessity of capital raising following a cash
capital reduction (applicable to companies that have conducted a cash
capital reduction in the current year or the preceding year):None.
23.Any other matters that need to be specified:
(1)After obtaining approval from the competent authorities, the bonds will
apply for listing in TPEx or other offshore exchanges.
(2)The issuance terms and conditions and relevant matters of the bonds
are authorized at the Chairman's discretion.